Robert Hazlett

Stock Analyst at BTIG

(2.55)
# 885
Out of 5,218 analysts
47
Total ratings
36.00%
Success rate
73.69%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
Aura Biosciences
Maintains: Strong Buy
21 24
8.41 185.37% 3 Oct 18, 2024
Nektar Therapeutics
Assumes: Buy
4
1 300% 2 Sep 30, 2024
Rani Therapeutics Hl...
Maintains: Strong Buy
7 14
1.65 748.48% 2 May 9, 2024
Aravive
Downgrades: Neutral
n/a
n/a n/a 2 Aug 3, 2023
Seelos Therapeutics
Maintains: Buy
42240 15360
n/a n/a 5 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
24 20
0.18 11011.11% 1 Feb 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
62 98
90.01 8.88% 2 Dec 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
96 60
4.49 1236.3% 3 Oct 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1710 1440
n/a n/a 1 Sep 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
522 216
n/a n/a 3 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Feb 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
15
0.03 49900% 3 Dec 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
n/a n/a 1 Aug 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
63
4.22 1392.89% 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
280
0.03 933233.33% 2 Apr 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
29
12.79 126.74% 4 Feb 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 40
83.02 -51.82% 2 Nov 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26000
7.44 349362.37% 1 Sep 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
26 6
1.84 226.09% 2 Sep 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 27
8.69 210.7% 2 Oct 16, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
32
n/a n/a 1 Aug 31, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
13
n/a n/a 1 Apr 21, 2017